Argentum Pharmaceuticals
17 articles about Argentum Pharmaceuticals
-
Argentum Pharmaceuticals Wins Patent Invalidation Trial Against Patent on Valeant's JUBLIA®
6/8/2018
On June 6, 2018, the U.S. Patent & Trademark Office issued a final written decision in favor of Argentum Pharmaceuticals, finding all claims of U.S. Patent No. 7,214,506 to be unpatentable for obviousness.
-
Sun Pharma received approval from the U.S. Food and Drug Administration (FDA) for Yonsa (abiraterone acetate) to treat metastatic castration-resistant prostate cancer (mCRPC). Sun will launch the drug in the U.S. via a licensing deal with Churchill Pharmaceuticals, the original developer of the d...
-
Argentum and Cosmo Settle Patent Dispute Over UCERIS®
4/24/2018
Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement agreement with Cosmo Technologies Limited related to Argentum's inter partes review petition challenging an Orange Book-listed patent for UCERIS® (budesonide).
-
Argentum Pharma Wins Patent Invalidation Trial Against the Sole Remaining Patent Protecting Janssen's ZYTIGA
1/18/2018
In today's decision, the PTO concluded that Argentum "satisfied its burden of demonstrating, by a preponderance of the evidence, that the subject matter of claims 1-20 would have been obvious," and therefore ordered "that claims 1-20 are held unpatentable."
-
Argentum Pharma Succeeds in Starting Patent Cancellation Trial Against Valeant's JUBLIA
11/14/2017
Today, the U.S. Patent & Trademark Office granted Argentum Pharma's petition for IPR against all patent claims in the first patent listed in the FDA's Orange Book as covering Valeant's JUBLIA. Argentum is challenging all claims of U.S. Patent No. 7,214,506.
-
Argentum Succeeds In Starting Patent Cancellation Trial Against Novartis AG' AFINITOR
10/2/2017
-
Argentum Succeeds In Starting Patent Cancellation Trial Against Mylan's DYMISTA
10/2/2017
-
Argentum Succeeds In Starting Patent Cancellation Trial Against Alcon's TRAVATAN Z
10/2/2017
-
Argentum And Eli Lilly Settle Patent Dispute Over CIALIS
8/23/2017
-
Argentum Succeeds In Starting Patent Cancellation Trial Against Novartis AG' GILENYA
8/11/2017
-
Argentum And Allergan Settle Patent Dispute Over RESTASIS
4/19/2017
-
Argentum Persists In Challenging The "Evergreening" Patent On UCB, Inc.'s VIMPAT
3/24/2017
-
Argentum And Alcon Settle Patent Dispute Over PAZEO
12/1/2016
-
Argentum Succeeds In Starting Patent Cancellation Trial Against Janssen's ZYTIGA
9/19/2016
-
Argentum And KVK Tech Succeed In Starting Patent Cancellation Trial Against Alcon's PAZEO
8/2/2016
-
Argentum Succeeds In Starting Patent Cancellation Trial Against UCB, Inc.'s VIMPAT
5/24/2016
-
KVK Tech And Argentum Announce Partnership To Commercialize Pharmaceutical Products Made In The U.S.A.
2/2/2016